EX-23.1 3 ea025595201ex23-1_adial.htm CONSENT OF MARCUM LLP

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 4, 2025 with respect to the financial statements of Adial Pharmaceuticals, Inc. for the years ended December 31, 2024, and 2023 included in the Annual Report on Form 10-K.

 

/s/ Marcum LLP  
   
Marlton, New Jersey  
September 9, 2025